ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Psoriasis Biosimilar Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-6S18549
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Psoriasis Biosimilar Market Research Report 2024
BUY CHAPTERS

Global Psoriasis Biosimilar Market Research Report 2024

Code: QYRE-Auto-6S18549
Report
September 2024
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck KGaA
Gyros Protein Technologies AB
Pfizer Inc
Novartis International AG
Amgen Inc
Samsung Bioepis Co., Ltd.
Coherus BioSciences
Hoffmann-La Roche Ltd
Celltrion
Samsung Bioepis
Sandoz Inc
Fresenius Kabi
Viatris
Reddy's Laboratories
GenScript

Psoriasis Biosimilar Market

A psoriasis biosimilar refers to a biologic drug that is highly similar to an existing FDA-approved biologic treatment (the reference product) used for treating psoriasis, a chronic autoimmune condition that causes rapid skin cell turnover, leading to scales and inflamed patches of skin. Biosimilars are developed after the original biologic's patent expires and are designed to be equally effective, safe, and of the same high quality as the original.
The global Psoriasis Biosimilar market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Psoriasis Biosimilar is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Psoriasis Biosimilar is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Psoriasis Biosimilar include Merck KGaA, Gyros Protein Technologies AB, Pfizer Inc., Novartis International AG, Amgen Inc, Samsung Bioepis Co., Ltd., Coherus BioSciences, Hoffmann-La Roche Ltd, Celltrion, Samsung Bioepis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Psoriasis Biosimilar, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriasis Biosimilar.
The Psoriasis Biosimilar market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Psoriasis Biosimilar market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriasis Biosimilar manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Psoriasis Biosimilar Market Report

Report Metric Details
Report Name Psoriasis Biosimilar Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck KGaA, Gyros Protein Technologies AB, Pfizer Inc., Novartis International AG, Amgen Inc, Samsung Bioepis Co., Ltd., Coherus BioSciences, Hoffmann-La Roche Ltd, Celltrion, Samsung Bioepis, Sandoz, Fresenius Kabi, Viatris, Reddy's Laboratories, GenScript
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Psoriasis Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Psoriasis Biosimilar in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Psoriasis Biosimilar Market report?

Ans: The main players in the Psoriasis Biosimilar Market are Merck KGaA, Gyros Protein Technologies AB, Pfizer Inc., Novartis International AG, Amgen Inc, Samsung Bioepis Co., Ltd., Coherus BioSciences, Hoffmann-La Roche Ltd, Celltrion, Samsung Bioepis, Sandoz, Fresenius Kabi, Viatris, Reddy's Laboratories, GenScript

What are the Application segmentation covered in the Psoriasis Biosimilar Market report?

Ans: The Applications covered in the Psoriasis Biosimilar Market report are Plaque Psoriasis, Psoriatic Arthritis, Other

What are the Type segmentation covered in the Psoriasis Biosimilar Market report?

Ans: The Types covered in the Psoriasis Biosimilar Market report are TNF-Alpha Inhibitors (Infliximab, Etanercept, Adalimumab), Other Biosimilars

Recommended Reports

Psoriasis & Arthritis

Autoimmune Biosimilars

Treatment Markets

1 Psoriasis Biosimilar Market Overview
1.1 Product Definition
1.2 Psoriasis Biosimilar by Type
1.2.1 Global Psoriasis Biosimilar Market Value Comparison by Type (2024-2030)
1.2.2 TNF-Alpha Inhibitors (Infliximab, Etanercept, Adalimumab)
1.2.3 Other Biosimilars
1.3 Psoriasis Biosimilar by Application
1.3.1 Global Psoriasis Biosimilar Market Value by Application (2024-2030)
1.3.2 Plaque Psoriasis
1.3.3 Psoriatic Arthritis
1.3.4 Other
1.4 Global Psoriasis Biosimilar Market Size Estimates and Forecasts
1.4.1 Global Psoriasis Biosimilar Revenue 2019-2030
1.4.2 Global Psoriasis Biosimilar Sales 2019-2030
1.4.3 Global Psoriasis Biosimilar Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Psoriasis Biosimilar Market Competition by Manufacturers
2.1 Global Psoriasis Biosimilar Sales Market Share by Manufacturers (2019-2024)
2.2 Global Psoriasis Biosimilar Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Psoriasis Biosimilar Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Psoriasis Biosimilar, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Psoriasis Biosimilar, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Psoriasis Biosimilar, Product Type & Application
2.7 Global Key Manufacturers of Psoriasis Biosimilar, Date of Enter into This Industry
2.8 Global Psoriasis Biosimilar Market Competitive Situation and Trends
2.8.1 Global Psoriasis Biosimilar Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Psoriasis Biosimilar Players Market Share by Revenue
2.8.3 Global Psoriasis Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Psoriasis Biosimilar Market Scenario by Region
3.1 Global Psoriasis Biosimilar Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Psoriasis Biosimilar Sales by Region: 2019-2030
3.2.1 Global Psoriasis Biosimilar Sales by Region: 2019-2024
3.2.2 Global Psoriasis Biosimilar Sales by Region: 2025-2030
3.3 Global Psoriasis Biosimilar Revenue by Region: 2019-2030
3.3.1 Global Psoriasis Biosimilar Revenue by Region: 2019-2024
3.3.2 Global Psoriasis Biosimilar Revenue by Region: 2025-2030
3.4 North America Psoriasis Biosimilar Market Facts & Figures by Country
3.4.1 North America Psoriasis Biosimilar Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Psoriasis Biosimilar Sales by Country (2019-2030)
3.4.3 North America Psoriasis Biosimilar Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Psoriasis Biosimilar Market Facts & Figures by Country
3.5.1 Europe Psoriasis Biosimilar Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Psoriasis Biosimilar Sales by Country (2019-2030)
3.5.3 Europe Psoriasis Biosimilar Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Psoriasis Biosimilar Market Facts & Figures by Region
3.6.1 Asia Pacific Psoriasis Biosimilar Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Psoriasis Biosimilar Sales by Region (2019-2030)
3.6.3 Asia Pacific Psoriasis Biosimilar Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Psoriasis Biosimilar Market Facts & Figures by Country
3.7.1 Latin America Psoriasis Biosimilar Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Psoriasis Biosimilar Sales by Country (2019-2030)
3.7.3 Latin America Psoriasis Biosimilar Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Psoriasis Biosimilar Market Facts & Figures by Country
3.8.1 Middle East and Africa Psoriasis Biosimilar Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Psoriasis Biosimilar Sales by Country (2019-2030)
3.8.3 Middle East and Africa Psoriasis Biosimilar Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Psoriasis Biosimilar Sales by Type (2019-2030)
4.1.1 Global Psoriasis Biosimilar Sales by Type (2019-2024)
4.1.2 Global Psoriasis Biosimilar Sales by Type (2025-2030)
4.1.3 Global Psoriasis Biosimilar Sales Market Share by Type (2019-2030)
4.2 Global Psoriasis Biosimilar Revenue by Type (2019-2030)
4.2.1 Global Psoriasis Biosimilar Revenue by Type (2019-2024)
4.2.2 Global Psoriasis Biosimilar Revenue by Type (2025-2030)
4.2.3 Global Psoriasis Biosimilar Revenue Market Share by Type (2019-2030)
4.3 Global Psoriasis Biosimilar Price by Type (2019-2030)
5 Segment by Application
5.1 Global Psoriasis Biosimilar Sales by Application (2019-2030)
5.1.1 Global Psoriasis Biosimilar Sales by Application (2019-2024)
5.1.2 Global Psoriasis Biosimilar Sales by Application (2025-2030)
5.1.3 Global Psoriasis Biosimilar Sales Market Share by Application (2019-2030)
5.2 Global Psoriasis Biosimilar Revenue by Application (2019-2030)
5.2.1 Global Psoriasis Biosimilar Revenue by Application (2019-2024)
5.2.2 Global Psoriasis Biosimilar Revenue by Application (2025-2030)
5.2.3 Global Psoriasis Biosimilar Revenue Market Share by Application (2019-2030)
5.3 Global Psoriasis Biosimilar Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck KGaA
6.1.1 Merck KGaA Company Information
6.1.2 Merck KGaA Description and Business Overview
6.1.3 Merck KGaA Psoriasis Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck KGaA Psoriasis Biosimilar Product Portfolio
6.1.5 Merck KGaA Recent Developments/Updates
6.2 Gyros Protein Technologies AB
6.2.1 Gyros Protein Technologies AB Company Information
6.2.2 Gyros Protein Technologies AB Description and Business Overview
6.2.3 Gyros Protein Technologies AB Psoriasis Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Gyros Protein Technologies AB Psoriasis Biosimilar Product Portfolio
6.2.5 Gyros Protein Technologies AB Recent Developments/Updates
6.3 Pfizer Inc.
6.3.1 Pfizer Inc. Company Information
6.3.2 Pfizer Inc. Description and Business Overview
6.3.3 Pfizer Inc. Psoriasis Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Inc. Psoriasis Biosimilar Product Portfolio
6.3.5 Pfizer Inc. Recent Developments/Updates
6.4 Novartis International AG
6.4.1 Novartis International AG Company Information
6.4.2 Novartis International AG Description and Business Overview
6.4.3 Novartis International AG Psoriasis Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis International AG Psoriasis Biosimilar Product Portfolio
6.4.5 Novartis International AG Recent Developments/Updates
6.5 Amgen Inc
6.5.1 Amgen Inc Company Information
6.5.2 Amgen Inc Description and Business Overview
6.5.3 Amgen Inc Psoriasis Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Amgen Inc Psoriasis Biosimilar Product Portfolio
6.5.5 Amgen Inc Recent Developments/Updates
6.6 Samsung Bioepis Co., Ltd.
6.6.1 Samsung Bioepis Co., Ltd. Company Information
6.6.2 Samsung Bioepis Co., Ltd. Description and Business Overview
6.6.3 Samsung Bioepis Co., Ltd. Psoriasis Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Samsung Bioepis Co., Ltd. Psoriasis Biosimilar Product Portfolio
6.6.5 Samsung Bioepis Co., Ltd. Recent Developments/Updates
6.7 Coherus BioSciences
6.7.1 Coherus BioSciences Company Information
6.7.2 Coherus BioSciences Description and Business Overview
6.7.3 Coherus BioSciences Psoriasis Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Coherus BioSciences Psoriasis Biosimilar Product Portfolio
6.7.5 Coherus BioSciences Recent Developments/Updates
6.8 Hoffmann-La Roche Ltd
6.8.1 Hoffmann-La Roche Ltd Company Information
6.8.2 Hoffmann-La Roche Ltd Description and Business Overview
6.8.3 Hoffmann-La Roche Ltd Psoriasis Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hoffmann-La Roche Ltd Psoriasis Biosimilar Product Portfolio
6.8.5 Hoffmann-La Roche Ltd Recent Developments/Updates
6.9 Celltrion
6.9.1 Celltrion Company Information
6.9.2 Celltrion Description and Business Overview
6.9.3 Celltrion Psoriasis Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Celltrion Psoriasis Biosimilar Product Portfolio
6.9.5 Celltrion Recent Developments/Updates
6.10 Samsung Bioepis
6.10.1 Samsung Bioepis Company Information
6.10.2 Samsung Bioepis Description and Business Overview
6.10.3 Samsung Bioepis Psoriasis Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Samsung Bioepis Psoriasis Biosimilar Product Portfolio
6.10.5 Samsung Bioepis Recent Developments/Updates
6.11 Sandoz
6.11.1 Sandoz Company Information
6.11.2 Sandoz Description and Business Overview
6.11.3 Sandoz Psoriasis Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sandoz Psoriasis Biosimilar Product Portfolio
6.11.5 Sandoz Recent Developments/Updates
6.12 Fresenius Kabi
6.12.1 Fresenius Kabi Company Information
6.12.2 Fresenius Kabi Description and Business Overview
6.12.3 Fresenius Kabi Psoriasis Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Fresenius Kabi Psoriasis Biosimilar Product Portfolio
6.12.5 Fresenius Kabi Recent Developments/Updates
6.13 Viatris
6.13.1 Viatris Company Information
6.13.2 Viatris Description and Business Overview
6.13.3 Viatris Psoriasis Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Viatris Psoriasis Biosimilar Product Portfolio
6.13.5 Viatris Recent Developments/Updates
6.14 Reddy's Laboratories
6.14.1 Reddy's Laboratories Company Information
6.14.2 Reddy's Laboratories Description and Business Overview
6.14.3 Reddy's Laboratories Psoriasis Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Reddy's Laboratories Psoriasis Biosimilar Product Portfolio
6.14.5 Reddy's Laboratories Recent Developments/Updates
6.15 GenScript
6.15.1 GenScript Company Information
6.15.2 GenScript Description and Business Overview
6.15.3 GenScript Psoriasis Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.15.4 GenScript Psoriasis Biosimilar Product Portfolio
6.15.5 GenScript Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Psoriasis Biosimilar Industry Chain Analysis
7.2 Psoriasis Biosimilar Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Psoriasis Biosimilar Production Mode & Process
7.4 Psoriasis Biosimilar Sales and Marketing
7.4.1 Psoriasis Biosimilar Sales Channels
7.4.2 Psoriasis Biosimilar Distributors
7.5 Psoriasis Biosimilar Customers
8 Psoriasis Biosimilar Market Dynamics
8.1 Psoriasis Biosimilar Industry Trends
8.2 Psoriasis Biosimilar Market Drivers
8.3 Psoriasis Biosimilar Market Challenges
8.4 Psoriasis Biosimilar Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck KGaA
Gyros Protein Technologies AB
Pfizer Inc
Novartis International AG
Amgen Inc
Samsung Bioepis Co., Ltd.
Coherus BioSciences
Hoffmann-La Roche Ltd
Celltrion
Samsung Bioepis
Sandoz Inc
Fresenius Kabi
Viatris
Reddy's Laboratories
GenScript
List of Tables
 Table 1. Global Psoriasis Biosimilar Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Psoriasis Biosimilar Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Psoriasis Biosimilar Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Psoriasis Biosimilar Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Psoriasis Biosimilar Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Psoriasis Biosimilar Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Psoriasis Biosimilar Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Psoriasis Biosimilar Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Psoriasis Biosimilar, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Psoriasis Biosimilar, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Psoriasis Biosimilar, Product Type & Application
 Table 12. Global Key Manufacturers of Psoriasis Biosimilar, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Psoriasis Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Biosimilar as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Psoriasis Biosimilar Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Psoriasis Biosimilar Sales by Region (2019-2024) & (K Units)
 Table 18. Global Psoriasis Biosimilar Sales Market Share by Region (2019-2024)
 Table 19. Global Psoriasis Biosimilar Sales by Region (2025-2030) & (K Units)
 Table 20. Global Psoriasis Biosimilar Sales Market Share by Region (2025-2030)
 Table 21. Global Psoriasis Biosimilar Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Psoriasis Biosimilar Revenue Market Share by Region (2019-2024)
 Table 23. Global Psoriasis Biosimilar Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Psoriasis Biosimilar Revenue Market Share by Region (2025-2030)
 Table 25. North America Psoriasis Biosimilar Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Psoriasis Biosimilar Sales by Country (2019-2024) & (K Units)
 Table 27. North America Psoriasis Biosimilar Sales by Country (2025-2030) & (K Units)
 Table 28. North America Psoriasis Biosimilar Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Psoriasis Biosimilar Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Psoriasis Biosimilar Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Psoriasis Biosimilar Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Psoriasis Biosimilar Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Psoriasis Biosimilar Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Psoriasis Biosimilar Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Psoriasis Biosimilar Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Psoriasis Biosimilar Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Psoriasis Biosimilar Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Psoriasis Biosimilar Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Psoriasis Biosimilar Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Psoriasis Biosimilar Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Psoriasis Biosimilar Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Psoriasis Biosimilar Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Psoriasis Biosimilar Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Psoriasis Biosimilar Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Psoriasis Biosimilar Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Psoriasis Biosimilar Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Psoriasis Biosimilar Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Psoriasis Biosimilar Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Psoriasis Biosimilar Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Psoriasis Biosimilar Sales (K Units) by Type (2019-2024)
 Table 51. Global Psoriasis Biosimilar Sales (K Units) by Type (2025-2030)
 Table 52. Global Psoriasis Biosimilar Sales Market Share by Type (2019-2024)
 Table 53. Global Psoriasis Biosimilar Sales Market Share by Type (2025-2030)
 Table 54. Global Psoriasis Biosimilar Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Psoriasis Biosimilar Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Psoriasis Biosimilar Revenue Market Share by Type (2019-2024)
 Table 57. Global Psoriasis Biosimilar Revenue Market Share by Type (2025-2030)
 Table 58. Global Psoriasis Biosimilar Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Psoriasis Biosimilar Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Psoriasis Biosimilar Sales (K Units) by Application (2019-2024)
 Table 61. Global Psoriasis Biosimilar Sales (K Units) by Application (2025-2030)
 Table 62. Global Psoriasis Biosimilar Sales Market Share by Application (2019-2024)
 Table 63. Global Psoriasis Biosimilar Sales Market Share by Application (2025-2030)
 Table 64. Global Psoriasis Biosimilar Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Psoriasis Biosimilar Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Psoriasis Biosimilar Revenue Market Share by Application (2019-2024)
 Table 67. Global Psoriasis Biosimilar Revenue Market Share by Application (2025-2030)
 Table 68. Global Psoriasis Biosimilar Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Psoriasis Biosimilar Price (US$/Unit) by Application (2025-2030)
 Table 70. Merck KGaA Company Information
 Table 71. Merck KGaA Description and Business Overview
 Table 72. Merck KGaA Psoriasis Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Merck KGaA Psoriasis Biosimilar Product
 Table 74. Merck KGaA Recent Developments/Updates
 Table 75. Gyros Protein Technologies AB Company Information
 Table 76. Gyros Protein Technologies AB Description and Business Overview
 Table 77. Gyros Protein Technologies AB Psoriasis Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Gyros Protein Technologies AB Psoriasis Biosimilar Product
 Table 79. Gyros Protein Technologies AB Recent Developments/Updates
 Table 80. Pfizer Inc. Company Information
 Table 81. Pfizer Inc. Description and Business Overview
 Table 82. Pfizer Inc. Psoriasis Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Pfizer Inc. Psoriasis Biosimilar Product
 Table 84. Pfizer Inc. Recent Developments/Updates
 Table 85. Novartis International AG Company Information
 Table 86. Novartis International AG Description and Business Overview
 Table 87. Novartis International AG Psoriasis Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Novartis International AG Psoriasis Biosimilar Product
 Table 89. Novartis International AG Recent Developments/Updates
 Table 90. Amgen Inc Company Information
 Table 91. Amgen Inc Description and Business Overview
 Table 92. Amgen Inc Psoriasis Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Amgen Inc Psoriasis Biosimilar Product
 Table 94. Amgen Inc Recent Developments/Updates
 Table 95. Samsung Bioepis Co., Ltd. Company Information
 Table 96. Samsung Bioepis Co., Ltd. Description and Business Overview
 Table 97. Samsung Bioepis Co., Ltd. Psoriasis Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Samsung Bioepis Co., Ltd. Psoriasis Biosimilar Product
 Table 99. Samsung Bioepis Co., Ltd. Recent Developments/Updates
 Table 100. Coherus BioSciences Company Information
 Table 101. Coherus BioSciences Description and Business Overview
 Table 102. Coherus BioSciences Psoriasis Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Coherus BioSciences Psoriasis Biosimilar Product
 Table 104. Coherus BioSciences Recent Developments/Updates
 Table 105. Hoffmann-La Roche Ltd Company Information
 Table 106. Hoffmann-La Roche Ltd Description and Business Overview
 Table 107. Hoffmann-La Roche Ltd Psoriasis Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Hoffmann-La Roche Ltd Psoriasis Biosimilar Product
 Table 109. Hoffmann-La Roche Ltd Recent Developments/Updates
 Table 110. Celltrion Company Information
 Table 111. Celltrion Description and Business Overview
 Table 112. Celltrion Psoriasis Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Celltrion Psoriasis Biosimilar Product
 Table 114. Celltrion Recent Developments/Updates
 Table 115. Samsung Bioepis Company Information
 Table 116. Samsung Bioepis Description and Business Overview
 Table 117. Samsung Bioepis Psoriasis Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Samsung Bioepis Psoriasis Biosimilar Product
 Table 119. Samsung Bioepis Recent Developments/Updates
 Table 120. Sandoz Company Information
 Table 121. Sandoz Description and Business Overview
 Table 122. Sandoz Psoriasis Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Sandoz Psoriasis Biosimilar Product
 Table 124. Sandoz Recent Developments/Updates
 Table 125. Fresenius Kabi Company Information
 Table 126. Fresenius Kabi Description and Business Overview
 Table 127. Fresenius Kabi Psoriasis Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Fresenius Kabi Psoriasis Biosimilar Product
 Table 129. Fresenius Kabi Recent Developments/Updates
 Table 130. Viatris Company Information
 Table 131. Viatris Description and Business Overview
 Table 132. Viatris Psoriasis Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Viatris Psoriasis Biosimilar Product
 Table 134. Viatris Recent Developments/Updates
 Table 135. Reddy's Laboratories Company Information
 Table 136. Reddy's Laboratories Description and Business Overview
 Table 137. Reddy's Laboratories Psoriasis Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Reddy's Laboratories Psoriasis Biosimilar Product
 Table 139. Reddy's Laboratories Recent Developments/Updates
 Table 140. GenScript Company Information
 Table 141. GenScript Description and Business Overview
 Table 142. GenScript Psoriasis Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. GenScript Psoriasis Biosimilar Product
 Table 144. GenScript Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Psoriasis Biosimilar Distributors List
 Table 148. Psoriasis Biosimilar Customers List
 Table 149. Psoriasis Biosimilar Market Trends
 Table 150. Psoriasis Biosimilar Market Drivers
 Table 151. Psoriasis Biosimilar Market Challenges
 Table 152. Psoriasis Biosimilar Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Psoriasis Biosimilar
 Figure 2. Global Psoriasis Biosimilar Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Psoriasis Biosimilar Market Share by Type: 2023 & 2030
 Figure 4. TNF-Alpha Inhibitors (Infliximab, Etanercept, Adalimumab) Product Picture
 Figure 5. Other Biosimilars Product Picture
 Figure 6. Global Psoriasis Biosimilar Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Psoriasis Biosimilar Market Share by Application: 2023 & 2030
 Figure 8. Plaque Psoriasis
 Figure 9. Psoriatic Arthritis
 Figure 10. Other
 Figure 11. Global Psoriasis Biosimilar Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Psoriasis Biosimilar Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Psoriasis Biosimilar Sales (2019-2030) & (K Units)
 Figure 14. Global Psoriasis Biosimilar Average Price (US$/Unit) & (2019-2030)
 Figure 15. Psoriasis Biosimilar Report Years Considered
 Figure 16. Psoriasis Biosimilar Sales Share by Manufacturers in 2023
 Figure 17. Global Psoriasis Biosimilar Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Psoriasis Biosimilar Players: Market Share by Revenue in Psoriasis Biosimilar in 2023
 Figure 19. Psoriasis Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Psoriasis Biosimilar Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Psoriasis Biosimilar Sales Market Share by Country (2019-2030)
 Figure 22. North America Psoriasis Biosimilar Revenue Market Share by Country (2019-2030)
 Figure 23. United States Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Psoriasis Biosimilar Sales Market Share by Country (2019-2030)
 Figure 26. Europe Psoriasis Biosimilar Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Psoriasis Biosimilar Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Psoriasis Biosimilar Revenue Market Share by Region (2019-2030)
 Figure 34. China Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Psoriasis Biosimilar Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Psoriasis Biosimilar Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Psoriasis Biosimilar Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Psoriasis Biosimilar Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Psoriasis Biosimilar by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Psoriasis Biosimilar by Type (2019-2030)
 Figure 53. Global Psoriasis Biosimilar Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Psoriasis Biosimilar by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Psoriasis Biosimilar by Application (2019-2030)
 Figure 56. Global Psoriasis Biosimilar Price (US$/Unit) by Application (2019-2030)
 Figure 57. Psoriasis Biosimilar Value Chain
 Figure 58. Psoriasis Biosimilar Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Biologic Medications for Psoriasis Market Research Report 2024
Global Ustekinumab Biosimilars Market Research Report 2024
Biosimilars Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rituximab Biosimilars Market Research Report 2025
Global Biosimilar and Interchangeable Biologics Market Research Report 2024
Global Biosimilar Antibodies Market Research Report 2024
Global Monoclonal antibodies mAbs Biosimilars Market Research Report 2024
Global Osteoporosis Biosimilars Market Research Report 2025
Global Interchangeable Biosimilars Market Research Report 2024
Global Biosimilars and Innovative Biological Drugs Market Research Report 2024
Global Biopharmaceuticals for Psoriasis Market Research Report 2024
Biosimilar of Remicade Market
Enbrel Etanercept and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oncology Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Psoriasis Biologics Drugs Market Research Report 2025
Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Research Report 2024
Humira Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Infliximab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Interchangeable Biological Products Market Research Report 2024
Global Interleukin Inhibitors for Psoriasis Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions